P02.118. Oral chamomile (Matricaria recutita) extract therapy of Generalized Anxiety Disorder (GAD): trial in progress

广泛性焦虑症 医学 焦虑 传统医学 精神科
作者
Jun J. J. Mao,Robert J. DeRubeis,Q Li,James Baier,Daniel Cristancho,J Hollm,Jared D. Minkel,Jay D. Amsterdam
出处
期刊:BMC Complementary and Alternative Medicine [BioMed Central]
卷期号:12 (S1) 被引量:1
标识
DOI:10.1186/1472-6882-12-s1-p174
摘要

A 38-week long-term relapse prevention trial with three phases. I: Eight weeks to determine whether individuals respond to chamomile; II: Four more weeks among responders to determine whether symptoms remain stable; III: An additional 26 weeks to determine whether chamomile is superior to placebo in preventing the recurrence of anxiety symptoms in responders. Subjects meet DSM IV-TR criteria for GAD, moderate severity. Study interventions include pharmaceutical grade chamomile extract (SHR-5) 1,500 mg daily standardized to 1.2% apigenin and comparable placebo. Primary outcome measures are the GAD-7, Hamilton Anxiety Rating (HAM-A), and Clinical Global Impression Severity (CGI/S) scales. To date, 63 subjects have been enrolled, median age 48, range (24 to 71); 40 women, 23 men; 49 White, 6 African American, 6 Asian, 2 Other. Among the 48 subjects who completed phase I, a significant mean reduction of anxiety symptoms, as measured by GAD-7 (13.4 to 5.4, 59.7%, p≤0.001) and HAM-A (16.3 to 5.5, 66.2%, p≤0.001) have been observed. By a priori defined CGI-S and by 50% symptom reduction in GAD-7, 38 of those completing phase I (79.2%) met criteria for response. No serious adverse events were observed. Preliminary findings are consistent with our previous RCT finding that over 50% of subjects with moderate or severe GAD symptoms respond to chamomile. The 1500mg dose of chamomile oral extract appears to be safe. More definitive and long-term relapse prevention findings await the completion of the trial.

科研通智能强力驱动
Strongly Powered by AbleSci AI
科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
lmg完成签到,获得积分10
2秒前
3秒前
ghr777完成签到 ,获得积分10
3秒前
3秒前
123完成签到,获得积分20
3秒前
huanhuan发布了新的文献求助10
4秒前
SciGPT的应助被董晴采纳,获得10
4秒前
4秒前
xjh的应助被花样年华采纳,获得150
6秒前
6秒前
6秒前
gong完成签到,获得积分10
6秒前
巷阳完成签到,获得积分10
7秒前
丘比特的应助被RUI采纳,获得10
7秒前
赘婿的应助被王大橙子采纳,获得10
8秒前
威菡完成签到,获得积分10
8秒前
俊逸一手完成签到,获得积分10
8秒前
8秒前
华仔的应助被奋斗的凡采纳,获得10
8秒前
123发布了新的文献求助10
9秒前
9秒前
Sean发布了新的文献求助10
9秒前
Gloria2023发布了新的文献求助20
9秒前
li完成签到,获得积分10
9秒前
9秒前
传奇3的应助被1001采纳,获得10
10秒前
10秒前
涤宇发布了新的文献求助10
10秒前
11秒前
lydia完成签到,获得积分10
11秒前
cdercder的应助被何喝采纳,获得10
11秒前
坚强孤容发布了新的文献求助10
11秒前
xjh的应助被热情的远锋采纳,获得10
12秒前
爆米花的应助被gaofan采纳,获得10
12秒前
Joy发布了新的文献求助10
13秒前
13秒前
鸡你太美完成签到,获得积分10
13秒前
13秒前
lydia发布了新的文献求助10
14秒前
SciGPT的应助被向阳而开采纳,获得10
15秒前
高分求助中
(应助此贴封号)【重要!!请各用户(尤其是新用户)详细阅读】【科研通的精品贴汇总】 10000
拉伸高分子熔体中缠结行为的模拟和小角中子散射研究 1700
The World Atlas of Wine 9th edition 1000
奈特基础组织学:配套组织病理学(第4版)(Netter's Essential Histology With Correlated Histopathology) 800
八旗制度の研究 600
Improving the wear resistance of vehicle gear oil by oil soluble LaF3 nanoparticles and typical additives of gear oil 500
Boundaries and Bodhisattvas 500
热门求助领域 (近24小时)
化学 材料科学 医学 生物 纳米技术 计算机科学 工程类 有机化学 化学工程 生物化学 物理 复合材料 内科学 催化作用 光电子学 人工智能 细胞生物学 无机化学 物理化学 数学
热门帖子
关注 科研通微信公众号,转发送积分 8183204
求助须知:如何正确求助?哪些是违规求助? 9572434
关于积分的说明 21825655
捐赠科研通 7779988
什么是DOI,文献DOI怎么找? 3433852
关于科研通互助平台的介绍 2558060
邀请新用户注册赠送积分活动 2480148